DE VEGA'S TRICUSPID ANNULOPLASTY FOR SEVERE TRICUSPID REGURGITATION - EARLY AND MIDTERM FOLLOW UP

Abstract

Objective: To assess early and midterm outcome of De Vega's Repair of Tricuspid
Valve in Severe Tricuspid Regurgitation (TR).
Methodology: This was a prospective observational study conducted from
January 2007 to June 2011, at Cardiovascular department PGMI, Lady Reading
Hospital Peshawar. De Vega's surgical repair of tricuspid valve was done in
severe tricuspid regurgitation patients with mitral valve replacement (MVR) or
with double valve replacement [DVR=MVR+ AVR (Aortic valve replacement)].
Pre operative and post operative early (with in 1month) and midterm (at 6 month)
follow up data was collected and analyzed on the basis of New York Heart
Association (NYHA) functional status and echocardiographic finding. The
outcome of De Vega's repair was assessed.
Results: Total study population was 160, with age ranging from 14-52 years
(mean age 21 years). Out of these 160 patients 89 (55.60%) patients were female
and 71 (44.40%) were male. Preoperative diagnosis of 118 patients was related
to pure mitral valve disease, and 42 cases were having aortic valve disease along
with mitral disease. All patients had severe TR. Patients who were free from TR in
MVR group were 81.3% and 75.0% patient were TR free in DVR group at 6
months follow up and the repair was intact on echocardiography.
Conclusion: De Vega's repair in Severe TR is a safe and economical procedure in
our setup.